High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome

Abstract Background High‐dose‐rate brachytherapy (HDR BRT) has been enjoying rapid acceptance as a treatment modality offered to selected prostate cancer patients devoid of risk group, employed either in monotherapy setting or combined with external beam radiation therapy (EBRT) and is currently one...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Iosif Strouthos, Efstratios Karagiannis, Nikolaos Zamboglou, Konstantinos Ferentinos
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2022-01-01
Serija:	Cancer Reports
Teme:	combined with EBRT high‐dose‐rate interstitial brachytherapy monotherapy prostate cancer salvage
Online dostop:	https://doi.org/10.1002/cnr2.1450
Oznake:	Označite Brez oznak, prvi označite!